ARCHIVES

White House Preparing To Nominate Andrew von Eschenbach as FDA Commissioner, Sources Said

This article is from The Cancer Letter archive.

Vol. 32 No. 08 | March 3, 2006

Download PDF Visit The Full Archive

Related Articles

Wilex, Fox Chase, Begin Trial Of WX-UK1 Targeting Invasion

May 28, 2004

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

October 26, 2012

GlaxoSmithKline Partners With MD Anderson, Fred Hutchinson

December 14, 2012

In Their Own Words: “Blessed with The Opportunity” vs. “LOWEST Morale Ever”

May 23, 2014

NCAB Committee Agrees On Seven Characteristics For Comprehensive Centers, Asks For New Division

May 12, 1989

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

November 26, 2010